[HTML][HTML] Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review

…, L Nygård, MGM Olde-Rikkert, JM Orgogozo… - Alzheimer's research & …, 2015 - Springer
Introduction There is a growing body of evidence that subtle deficits in instrumental activities
of daily living (IADL) may be present in mild cognitive impairment (MCI). However, it is not …

Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia

…, DR Royall, RA Bullock, JM Orgogozo… - Journal of the …, 2004 - Elsevier
Vascular cognitive impairment (VCI) was proposed as an umbrella term to include subjects
affected with any degree of cognitive impairment resulting from cerebrovascular disease (…

Vascular dementia: diagnostic criteria for research studies: report of the NINDS‐AIREN International Workshop

…, JC Masdeu, JH Garcia, L Amaducci, JM Orgogozo… - Neurology, 1993 - AAN Enterprises
Criteria for the diagnosis of vascular dementia (VaD) that are reliable, valid, and readily
applicable in a variety of settings are urgently needed for both clinical and research purposes. …

Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization

JM Orgogozo, S Gilman, JF Dartigues, B Laurent… - Neurology, 2003 - AAN Enterprises
Background: AD is characterized by cerebral deposition of β-amyloid plaques with amyloid β-peptide
(Aβ) 42 as the major peptide constituent, along with neurofibrillary tangles and …

Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial

…, L Eisner, L Kirby, MB Rovira, F Forette, JM Orgogozo - Neurology, 2005 - AAN Enterprises
Background: AN1792 (beta-amyloid [Aβ]1–42) immunization reduces Aβ plaque burden
and preserves cognitive function in APP transgenic mice. The authors report the results of a …

Incidence and outcome of mild cognitive impairment in a population-based prospective cohort

S Larrieu, L Letenneur, JM Orgogozo, C Fabrigoule… - Neurology, 2002 - AAN Enterprises
Objective: To estimate the age-specific incidence rate of mild cognitive impairment (MCI)
according to sex and educational level and to explore the course of MCI, particularly its …

Prodromal Alzheimer's disease: successive emergence of the clinical symptoms

…, M Le Goff, X Millet, JM Orgogozo… - Annals of Neurology …, 2008 - Wiley Online Library
Objective Whereas cognitive deficits are known to be detectable long before the typical
symptoms of Alzheimer's disease (AD) are evident, previous studies have failed to determine …

Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300)

JM Orgogozo, AS Rigaud, A Stöffler, HJ Möbius… - Stroke, 2002 - Am Heart Assoc
Background and Purpose— Based on the hypothesis of glutamate-induced neurotoxicity (excitotoxicity)
in cerebral ischemia, this study examined the efficacy and tolerability of …

Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area.

JM Orgogozo, JF Dartigues, S Lafont… - Revue …, 1997 - europepmc.org
Alcoholism is a possible cause of dementia, mainly through associated nutritional deficiencies
and, rarely, through acute direct toxicity. However alcohol consumption was not found to …

Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?

…, S Gauthier, JC Morris, JM Orgogozo… - … Journal of Geriatric …, 2001 - Wiley Online Library
… , the European Medicine Evaluation Agency EMEA) issued new guidelines for trials of
symptomatic treatments in Alzheimer's disease EMEA, 1997) and vascular dementia Orgogozo